Charles Bankhead


BPH: Current, forthcoming modalities show efficacy

June 30, 2016

Four-year data on the prostatic urethral lift (UroLift) and data on a new water-jet ablation treatment were among BPH/LUTS highlights from this year’s meeting.

Antiandrogen for prostate cancer shows improvement in survival, quality of life

September 01, 2012

Men with previously treated castration-resistant prostate cancer (CRPC) lived almost 5 months longer when they received the androgen receptor signaling inhibitor enzalutamide.

Transurethral resection of the prostate associated with lower risk of repeat procedures

September 01, 2012

Repeat surgery occurs two to three times as often after newer minimally invasive interventions for BPH compared with transurethral resection of the prostate.

Robotic radical prostatectomy remains more costly than open technique

September 01, 2012

A robot-assisted laparoscopic radical prostatectomy costs 40% more than a retropubic radical prostatectomy, according to a review of hospital data from one state.